Caricamento...
Identification of a potent kinase inhibitor targeting EML4-ALK fusion protein in non-small cell lung cancer
ALK-fusion proteins play a fundamental role in the development of about 5% of non-small cell lung cancers. Herein, we identified the compound 5067-0952 as a potent ALK inhibitor, which inhibited cell growth, induced apoptosis, and suppressed the phosphorylation of ALK, subsequently blocking its down...
Salvato in:
| Pubblicato in: | Medchemcomm |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Royal Society of Chemistry
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6071718/ https://ncbi.nlm.nih.gov/pubmed/30108712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c7md00305f |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|